The UF Hematologic Malignancy and Cellular Therapy Program is one of 16 core centers in the NHLBI and NCI Blood and Marrow Transplant Clinical Trials Network, reflecting its national leadership in transplant and cellular therapies. The program works closely with the UF Health Cancer Institute Cell Biology Group to expand the applications of stem cell therapies and with the UF Diabetes Center to explore immunotherapy approaches in diabetes care, supporting a strong focus on innovation across oncology and translational science. Its clinical and research efforts are centered on developing and evaluating new therapeutic strategies for patients with hematologic malignancies while advancing the understanding of stem cell biology and improving outcomes in blood and marrow transplantation. This work is led by a highly specialized faculty and supported by robust clinical and research infrastructure, including a dedicated 20 bed inpatient unit, integrated outpatient clinic, stem cell laboratory, core blood and tissue bank, and stem cell collection facility.
For information on how to make an appointment, visit ufhealth.org/bmt.
Hematologic Malignancy and Cellular Therapy Faculty
| Profile Image | Name | Title | Business Phone | |
|---|---|---|---|---|
|
|
Dina Khalaf | CLIN ASO PROF | (352) 273-7832 | dina.khalaf@medicine.ufl.edu |
|
|
Muhammad J Tariq | CLIN AST PROF | (352) 273-7832 | tariq.mj@ufl.edu |
|
|
Ansh K Mehta | CLIN AST PROF | (352) 273-7832 | mehta.ak@ufl.edu |
|
|
Christopher R Cogle | Professor | (352) 273-7832 | christopher.cogle@medicine.ufl.edu |